13
views
0
recommends
+1 Recommend
2 collections
    0
    shares

          The flagship journal of the Society for Endocrinology. Learn more

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Heterogeneity of G protein activation by the calcium-sensing receptor

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The calcium-sensing receptor (CaSR) is a G protein-coupled receptor that plays a fundamental role in extracellular calcium (Ca 2+ e) homeostasis by regulating parathyroid hormone release and urinary calcium excretion. The CaSR has been described to activate all four G protein subfamilies (Gα q/11, Gα i/o, Gα 12/13, Gα s), and mutations in the receptor that cause hyper/hypocalcaemia, have been described to bias receptor signalling. However, many of these studies are based on measurements of second messengers or gene transcription that occurs many steps downstream of receptor activation and can represent convergence points of several signalling pathways. Therefore, to assess CaSR-mediated G protein activation directly, we took advantage of a recently described NanoBiT G protein dissociation assay system. Our studies, performed in HEK293 cells stably expressing CaSR, demonstrate that Ca 2+ e stimulation activates all Gα q/11 family and several Gα i/o family proteins, although Gα z was not activated. CaSR stimulated dissociation of Gα 12/13 and Gα s from Gβ-subunits, but this occurred at a slower rate than that of other Gα-subunits. Investigation of cDNA expression of G proteins in three tissues abundantly expressing CaSR, the parathyroids, kidneys and pancreas, showed Gα 11, Gα z, Gα i1 and Gα 13 genes were highly expressed in parathyroid tissue, indicating CaSR most likely activates Gα 11 and Gα i1 in parathyroids. In kidney and pancreas, the majority of G proteins were similarly expressed, suggesting CaSR may activate multiple G proteins in these cells. Thus, these studies validate a single assay system that can be used to robustly assess CaSR variants and biased signalling and could be utilised in the development of new pharmacological compounds targeting CaSR.

          Related collections

          Most cited references50

          • Record: found
          • Abstract: found
          • Article: not found

          Trends in GPCR drug discovery: new agents, targets and indications

          G protein-coupled receptors (GPCRs) are the most intensively studied drug targets, largely due to their substantial involvement in human pathophysiology and their pharmacological tractability. Here, we report the first analysis of all GPCR drugs and agents in clinical trials. This reveals the current trends across molecule types, drug targets and therapeutic indications, including showing that 481 drugs (~34% of all drugs approved by the FDA) act at 107 unique GPCR targets. Approximately 320 agents are currently in clinical trials, of which ~36% target 64 potentially novel GPCR targets without an approved drug, and the number of biological drugs, allosteric modulators and biased agonists has grown. The major disease indications for GPCR modulators show a shift towards diabetes, obesity, and Alzheimer’s disease, while other central nervous system disorders remain highly represented. The 227 (57%) non-olfactory GPCRs that are yet to be explored in clinical trials have broad untapped therapeutic potential, particularly in genetic and immune system disorders. Finally, we provide an interactive online resource to analyse and infer trends in GPCR drug discovery.
            • Record: found
            • Abstract: found
            • Article: not found

            PRESTO-TANGO: an open-source resource for interrogation of the druggable human GPCR-ome

            G protein-coupled receptors (GPCRs) are essential mediators of cellular signaling and important targets of drug action. Of the approximately 350 non-olfactory human GPCRs, more than 100 are still considered “orphans” as their endogenous ligand(s) remain unknown. Here, we describe a unique open-source resource that provides the capacity to interrogate the druggable human GPCR-ome via a G protein-independent β-arrestin recruitment assay. We validate this unique platform at more than 120 non-orphan human GPCR targets, demonstrate its utility for discovering new ligands for orphan human GPCRs, and describe a method (PRESTO-TANGO; Parallel Receptor-ome Expression and Screening via Transcriptional Output - TANGO) for the simultaneous and parallel interrogation of the entire human GPCR-ome.
              • Record: found
              • Abstract: found
              • Article: not found

              Anatomical profiling of G protein-coupled receptor expression.

              G protein-coupled receptors (GPCRs) comprise the largest family of transmembrane signaling molecules and regulate a host of physiological and disease processes. To better understand the functions of GPCRs in vivo, we quantified transcript levels of 353 nonodorant GPCRs in 41 adult mouse tissues. Cluster analysis placed many GPCRs into anticipated anatomical and functional groups and predicted previously unidentified roles for less-studied receptors. From one such prediction, we showed that the Gpr91 ligand succinate can regulate lipolysis in white adipose tissue, suggesting that signaling by this citric acid cycle intermediate may regulate energy homeostasis. We also showed that pairwise analysis of GPCR expression across tissues may help predict drug side effects. This resource will aid studies to understand GPCR function in vivo and may assist in the identification of therapeutic targets.

                Author and article information

                Journal
                J Mol Endocrinol
                J Mol Endocrinol
                JME
                Journal of Molecular Endocrinology
                Bioscientifica Ltd (Bristol )
                0952-5041
                1479-6813
                02 June 2021
                01 August 2021
                : 67
                : 2
                : 41-53
                Affiliations
                [1 ]Institute of Metabolism and Systems Research and Centre for Endocrinology , Diabetes and Metabolism, University of Birmingham, Birmingham, UK
                [2 ]Graduate School of Pharmaceutical Sciences , Tohoku University, Sendai, Miyagi, Japan
                [3 ]Centre of Membrane Proteins and Receptors (COMPARE) , Universities of Birmingham and Nottingham, UK
                Author notes
                Correspondence should be addressed to C M Gorvin: C.Gorvin@ 123456bham.ac.uk
                Author information
                http://orcid.org/0000-0002-1361-9174
                Article
                JME-21-0058
                10.1530/JME-21-0058
                8240730
                34077389
                b4cb1ffb-8eb0-4595-aaa0-31514d83fcb4
                © The authors

                This work is licensed under a Creative Commons Attribution 4.0 International License.

                History
                : 29 April 2021
                : 02 June 2021
                Categories
                Research

                Endocrinology & Diabetes
                calcium homeostasis,calcium signalling,g protein-coupled receptor,parathyroid and bone,signal transduction

                Comments

                Comment on this article

                Related Documents Log